TGFB3 protein, human: Clinical Trials

21 trials of TGFB3 protein, human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 2 unknown, 1 terminated, 1 withdrawn. 17 Phase 2, 10 Phase 1, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 217Completed 14, Unknown 2, Terminated 1
Phase 110Completed 10
Not applicable1Withdrawn 1
Phase 31Completed 1

Follow TGFB3 protein, human: new trials by email Literature Review of TGFB3 protein, human trials Research Report on TGFB3 protein, human

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial to Compare the Efficacy of Two Formulations of Avotermin Against Placebo
Juvista (Avotermin), RN1006 (Avotermin), Placebo - Scar Improvement
Phase 1CompletedRenovo842009-08-012010-12-09
Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids
Avotermin (Juvista), Placebo - Keloid
Phase 1 / Phase 2CompletedRenovo202009-02-012010-09-28
Juvista in the Non-surgical Improvement of Existing Scars
Juvista, Placebo - Scars
Not applicableWithdrawnRenovo402009-01-012010-03-09
Juvista in Scar Revision Surgery of Disfiguring Scars
Juvista (avotermin) - Cicatrix
Phase 3CompletedRenovo3502008-12-012011-03-03
Safety of Juvista When Administered Following Excision of Ear Lobe Keloids
Avotermin, placebo - Keloid
Phase 1 / Phase 2CompletedRenovo102008-07-012010-03-09
Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars
Avotermin - Keloid
Phase 1 / Phase 2CompletedRenovo202007-06-012009-09-16
Juvista (Avotermin) in Scars Following Varicose Vein Removal
Avotermin - Varicose Veins, Cicatrix
Phase 2CompletedRenovo1562006-11-012010-03-09
Juvista (Avotermin) in Breast Reduction Surgery Scars
Avotermin - Mammaplasty, Cicatrix
Phase 2TerminatedRenovo392006-10-012009-01-13
Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women
Avotermin (Juvista), Placebo - Cicatrix
Phase 2CompletedRenovo782006-09-012008-03-06
Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions
Avotermin, Placebo - Cicatrix
Phase 2CompletedRenovo392006-07-012008-03-04
Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.
Avotermin - Cicatrix
Phase 2UnknownRenovo602006-05-012009-02-04
RN1001(Avotermin) in Scar Improvement Following Breast Augmentation
Avotermin - Mammaplasty, Cicatrix
Phase 2CompletedRenovo632004-12-012008-08-14
A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision
Avotermin - Nevus, Cicatrix
Phase 2UnknownRenovo2392004-04-012008-04-11
Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males
Juvista (avotermin) plus placebo, standard-care (within-subject controls) - Cicatrix
Phase 2CompletedRenovo712003-10-012008-01-15
Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites
Avotermin, Placebo - Cicatrix, Wound Healing
Phase 2CompletedRenovo1022003-10-012009-09-25
Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects
Avotermin, Placebo - Cicatrix, Wound Healing
Phase 1 / Phase 2CompletedRenovo352003-04-012009-09-25
Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.
Avotermin, Placebo - Cicatrix
Phase 1 / Phase 2CompletedRenovo422002-09-012009-02-19
Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects
Intradermal avotermin, Placebo (vehicle), Placebo - Cicatrix, Wound Healing
Phase 1 / Phase 2CompletedRenovo202002-09-012009-09-16
Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)
Avotermin, Placebo - Cicatrix, Wound Healing
Phase 1 / Phase 2CompletedRenovo432002-02-012009-09-16
Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects
Avotermin (RN1001) - Cicatrix
Phase 1 / Phase 2CompletedRenovo1032001-11-012009-02-19

Showing 20 of 21. Sign in to see all of them.

Conditions studied

Cicatrix (17)  ·  Keloid (3)  ·  Arrhythmogenic Right Ventricular Dysplasia, Familial, 1 (2)  ·  Nevus (1)  ·  Varicose Veins (1)

Sponsors

Renovo (21)

Countries

United Kingdom (18)  ·  United States (4)  ·  Latvia (2)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Lithuania (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

Jonathan Duncan (4)  ·  Michael J Davies (3)  ·  James Bush, MBChB (2)  ·  Jeremy Bond (2)  ·  D A McGrouther, FRCS MD (1)  ·  D A McGrouther, FRCS, MD (1)  ·  David Whitby (1)  ·  James Bush (1)  ·  James Dr Bush, MBChB MRCS (1)  ·  Jim Bush, MB ChB (1)  ·  Jim Bush, MBChB (1)  ·  Jonathan Duncan, BS BCh (1)  ·  Jonathan Duncan, MB BCh (1)  ·  Leroy Young, MD (1)  ·  Peter McCollum, MB MCh FRCS (1)

Results publications

PMID 19362676, PMID 21042116, PMID 21618480, PMID 21701333